The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...

Highlighting studies that underscore how digital technology innovations enable improved self-management, personalized treatments, and seamless communication between patients and healthcare providers, ...

Scientists at Pennington Biomedical Research Center, along with a colleague from Peking University People's Hospital in China ...

NGGT Inc., ("Next Generation Gene Therapeutics" or "NGGT"), a clinical-stage biotechnology company pioneering the next wave of gene therapy innovation for genetic rare diseases, today announced ...

Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...